CMV Primary Infection Is Associated with Donor-Specific T Cell Hyporesponsiveness and Fewer Late Acute Rejections after Liver Transplantation

American Journal of Transplantation

Volumn 15, Issue 9, 2015, Pages 2431-2442

  Shi, X L ^a,b   De Mare Bredemeijer, E L D ^a   Tapirdamaz, O ^a   Hansen, B E ^a   Van Gent, R ^a   Van Campenhout, M J H ^a   Mancham, S ^a   Litjens, N H R ^a   Betjes, M G H ^a   Van Der Eijk, A A ^a   Xia, Q ^b   Van Der Laan, L J W ^a   De Jonge, J ^a   Metselaar, H J ^a   Kwekkeboom, J ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Cytomegalovirus (CMV); donor specific hyporesponsiveness; hepatology; immunobiology; infection and infectious agents; infectious disease; liver transplantation; rejection; science; T cell biology; tolerance; translational research; viral

Indexed keywords

ACUTE GRAFT REJECTION; ADOLESCENT; ADULT; AGED; ALLOGRAFT; ALLOIMMUNITY; ARTICLE; CD8+ T LYMPHOCYTE; CELL EXPANSION; COHORT ANALYSIS; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; DISEASE ASSOCIATION; EFFECTOR CELL; EX VIVO STUDY; EXPLANT; FEMALE; FLOW CYTOMETRY; GAMMA DELTA T LYMPHOCYTE; HUMAN; HUMAN CELL; HUMAN TISSUE; LIVER TRANSPLANTATION; LYMPHOCYTE DIFFERENTIATION; LYMPHOCYTIC INFILTRATION; MAJOR CLINICAL STUDY; MALE; MEMORY T LYMPHOCYTE; PHENOTYPE; PRIMARY INFECTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; T LYMPHOCYTE SUBPOPULATION; TRANSPLANTATION TOLERANCE; ALLOTRANSPLANTATION; CHILD; CYTOMEGALOVIRUS; DONOR; FOLLOW UP; GRAFT REJECTION; GRAFT SURVIVAL; IMMUNOLOGY; IMMUNOSUPPRESSIVE TREATMENT; LIVER DISEASES; MIDDLE AGED; PATHOLOGY; POSTOPERATIVE COMPLICATION; PROGNOSIS; RISK FACTOR; VIROLOGY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; CD8-POSITIVE T-LYMPHOCYTES; CHILD; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; FEMALE; FOLLOW-UP STUDIES; GRAFT REJECTION; GRAFT SURVIVAL; HUMANS; IMMUNOSUPPRESSION; LIVER DISEASES; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; PROGNOSIS; RETROSPECTIVE STUDIES; RISK FACTORS; TISSUE DONORS; TRANSPLANTATION, HOMOLOGOUS; YOUNG ADULT;

EID: 84939568977     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/ajt.13288     Document Type: Article

References (48)

1. Razonable RR, Emery VC., Management of CMV infection and disease in transplant patients. Herpes 2004; 11: 77-86.
2. Adams AB, Pearson TC, Larsen CP., Heterologous immunity: An overlooked barrier to tolerance. Immunol Rev 2003; 196: 147-160.
3. Cook CH, Bickerstaff AA, Wang JJ, et al., Disruption of murine cardiac allograft acceptance by latent cytomegalovirus. Am J Transplant 2009; 9: 42-53.
4. Carlquist JF, Shelby J, Shao YL, Greenwood JH, Hammond ME, Anderson JL., Accelerated rejection of murine cardiac allografts by murine cytomegalovirus-infected recipients. Lack of haplotype specificity. J Clin Invest 1993; 91: 2602-2608.
5. Adams AB, Williams MA, Jones TR, et al., Heterologous immunity provides a potent barrier to transplantation tolerance. J Clin Invest 2003; 111: 1887-1895.
6. Cainelli F, Vento S., Infections and solid organ transplant rejection: A cause-and-effect relationship ? Lancet Infect Dis 2002; 2: 539-549.
7. Sanchez-Fueyo A, Strom TB., Immunologic basis of graft rejection and tolerance following transplantation of liver or other solid organs. Gastroenterology 2011; 140: 51-64.
8. Macedo C, Orkis EA, Popescu I, et al., Contribution of naive and memory T-cell populations to the human alloimmune response. Am J Transplant 2009; 9: 2057-2066.
9. Appay V, van Lier RA, Sallusto F, Roederer M., Phenotype and function of human T lymphocyte subsets: Consensus and issues. Cytometry A 2008; 73: 975-983.
10. Sallusto F, Geginat J, Lanzavecchia A., Central memory and effector memory T cell subsets: Function, generation, and maintenance. Annu Rev Immunol 2004; 22: 745-763.
11. Pawelec G, Derhovanessian E., Role of CMV in immune senescence. Virus Res 2011; 157: 175-179.
12. Goronzy JJ, Fulbright JW, Crowson CS, Poland GA, O'Fallon WM, Weyand CM., Value of immunological markers in predicting responsiveness to influenza vaccination in elderly individuals. J Virol 2001; 75: 12182-12187.
13. Saurwein-Teissl M, Lung TL, Marx F, et al., Lack of antibody production following immunization in old age: Association with CD8(+)CD28(-) T cell clonal expansions and an imbalance in the production of Th1 and Th2 cytokines. J Immunol 2002; 168: 5893-5899.
14. D'Orsogna LJ, Roelen DL, Doxiadis II, Claas FH., Alloreactivity from human viral specific memory T-cells. Transpl Immunol 2010; 23: 149-155.
15. Amir AL, D'Orsogna LJ, Roelen DL, et al., Allo-HLA reactivity of virus-specific memory T cells is common. Blood 2010; 115: 3146-3157.
16. Li Y, Koshiba T, Yoshizawa A, et al., Analyses of peripheral blood mononuclear cells in operational tolerance after pediatric living donor liver transplantation. Am J Transplant 2004; 4: 2118-2125.
17. Martinez-Llordella M, Puig-Pey I, Orlando G, et al., Multiparameter immune profiling of operational tolerance in liver transplantation. Am J Transplant 2007; 7: 309-319.
18. Bohne F, Londono MC, Benitez C, et al., HCV-induced immune responses influence the development of operational tolerance after liver transplantation in humans. Sci Transl Med 2014; 6: 242ra281.
19. Litjens NH, de Wit EA, Baan CC, Betjes MG., Activation-induced CD137 is a fast assay for identification and multi-parameter flow-cytometric analysis of alloreactive T cells. Clin Exp Immunol 2013; 174: 179-191.
20. + T cells responding to antigen without requiring knowledge of epitope specificities. Blood 2007; 110: 201-210.
21. Tome S, Varo E., Impact and prevention of late acute rejection in liver transplant recipients. Trends Transplant 2010; 4: 29-35.
22. + T cells in a subset of clinically stable kidney transplant recipients: A potential marker for late graft dysfunction. J Am Soc Nephrol 2014; 25: 1856-1868.
23. EMRA cells are associated with the risk for acute kidney allograft rejection. Transplantation 2012; 94: 63-69.
24. Macedo C, Walters JT, Orkis EA, et al., Long-term effects of alemtuzumab on regulatory and memory T-cell subsets in kidney transplantation. Transplantation 2012; 93: 813-821.
25. + T-cells. Mech Ageing Dev 2010; 131: 96-104.
26. Mekker A, Tchang VS, Haeberli L, Oxenius A, Trkola A, Karrer U., Immune senescence: Relative contributions of age and cytomegalovirus infection. PLoS Pathog 2012; 8: e1002850.
27. + T-cell repertoire. J Virol 2007; 81: 7759-7765.
28. Cicin-Sain L, Brien JD, Uhrlaub JL, Drabig A, Marandu TF, Nikolich-Zugich J., Cytomegalovirus infection impairs immune responses and accentuates T-cell pool changes observed in mice with aging. PLoS Pathog 2012; 8: e1002849.
29. Smithey MJ, Li G, Venturi V, Davenport MP, Nikolich-Zugich J., Lifelong persistent viral infection alters the naive T cell pool, impairing CD8 T cell immunity in late life. J Immunol 2012; 189: 5356-5366.
30. Eid AJ, Razonable RR., Cytomegalovirus disease in solid organ transplant recipients: Advances lead to new challenges and opportunities. Curr Opin Organ Tran 2007; 12: 610-617.
31. Nickel P, Bold G, Presber F, et al., High levels of CMV-IE-1-specific memory T cells are associated with less alloimmunity and improved renal allograft function. Transpl Immunol 2009; 20: 238-242.
32. Tu W, Potena L, Stepick-Biek P, et al., T-cell immunity to subclinical cytomegalovirus infection reduces cardiac allograft disease. Circulation 2006; 114: 1608-1615.
33. Noriega V, Redmann V, Gardner T, Tortorella D., Diverse immune evasion strategies by human cytomegalovirus. Immunol Res 2012; 54: 140-151.
34. Alexander SI, Smith N, Hu M, et al., Chimerism and tolerance in a recipient of a deceased-donor liver transplant. N Engl J Med 2008; 358: 369-374.
35. Shi X, Moroso V, Metselaar HJ, Kwekkeboom J., Long-lived intragraft donor leukocytes or relocated donor hematopoietic stem/progenitor cells can cause long-term hematopoietic chimerism after liver transplantation. Hepatology 2013; 57: 2542.
36. Ueta H, Shi C, Miyanari N, et al., Systemic transmigration of allosensitizing donor dendritic cells to host secondary lymphoid organs after rat liver transplantation. Hepatology 2008; 47: 1352-1362.
37. Bosma BM, Metselaar HJ, Gerrits JH, et al., Migration of allosensitizing donor myeloid dendritic cells into recipients after liver transplantation. Liver Transplant 2010; 16: 12-22.
38. Frascaroli G, Varani S, Mastroianni A, et al., Dendritic cell function in cytomegalovirus-infected patients with mononucleosis. J Leukoc Biol 2006; 79: 932-940.
39. Nichols WG, Corey L, Gooley T, Davis C, Boeckh M., High risk of death due to bacterial and fungal infection among cytomegalovirus (CMV)-seronegative recipients of stem cell transplants from seropositive donors: Evidence for indirect effects of primary CMV infection. J Infect Dis 2002; 185: 273-282.
40. Hummel M, Abecassis MM., A model for reactivation of CMV from latency. J Clin Virol 2002; 25: S123-S136.
41. Wiesner RH, Demetris AJ, Belle SH, et al., Acute hepatic allograft rejection: Incidence, risk factors, and impact on outcome. Hepatology 1998; 28: 638-645.
42. Busuttil RW, Mcdiarmid S, Klintmalm GB, et al., A comparison of tacrolimus (FK 506) and cyclosporine for immunosuppression in liver transplantation. The U.S. Multicenter FK506 Liver Study Group. N Engl J Med 1994; 331: 1110-1115.
43. Neuhaus P, Clavien PA, Kittur D, et al., Improved treatment response with basiliximab immunoprophylaxis after liver transplantation: Results from a double-blind randomized placebo-controlled trial. Liver Transpl 2002; 8: 132-142.
44. - transplant recipients. Am J Transplant 2005; 5: 1065-1070.
45. Benitez C, Londono MC, Miquel R, et al., Prospective multicenter clinical trial of immunosuppressive drug withdrawal in stable adult liver transplant recipients. Hepatology 2013; 58: 1824-1835.
46. Bohne F, Martinez-Llordella M, Lozano JJ, et al., Intra-graft expression of genes involved in iron homeostasis predicts the development of operational tolerance in human liver transplantation. J Clin Invest 2012; 122: 368-382.
47. Pitard V, Roumanes D, Lafarge X, et al., Long-term expansion of effector/memory V delta 2(-) gamma delta T cells is a specific blood signature of CMV infection. Blood 2008; 112: 1317-1324.
48. Puig-Pey I, Bohne F, Benitez C, et al., Characterization of gammadelta T cell subsets in organ transplantation. Transpl Int 2010; 23: 1045-1055.